Latest papers

How long do the systemic and ventilatory responses to toluene diisocyanate persist in dermally sensitized mice?

[Toluene diisocyanate increases vascular endothelial growth factor expression in human bronchial epithelial cells].

Influence of genetic factors on toluene diisocyanate-related symptoms: evidence from a cross-sectional study.

PTEN down-regulates IL-17 expression in a murine model of toluene diisocyanate-induced airway disease.

[Determination and analysis of toluene diisocyanate metabolites in mice using gas chromatography-mass spectrometry].

Eye and airway symptoms in low occupational exposure to toluene diisocyanate.

Inhalation of toluene diisocyanate vapor induces allergic rhinitis in mice.

On imparting radiopacity to a poly(urethane urea).

The effect of monomers on the formulation of polymeric nanocapsules based on polyureas and polyamides.

Airway inflammation and bronchial remodelling in toluene diisocyanate-exposed BALB/c mouse model.

Rechallenging subjects with occupational asthma due to toluene diisocyanate (TDI), after long-term removal from exposure.

[From risk communication to participant decisions].

Maternal allergic contact dermatitis causes increased asthma risk in offspring.

Immunological determinants of ventilatory changes induced in mice by dermal sensitization and respiratory challenge with toluene diisocyanate.

Determination of isocyanate biomarkers in construction site workers.

Cytokeratin autoantibodies: useful serologic markers for toluene diisocyanate-induced asthma.

Pharmacological profile of a novel phosphodiesterase 7A and -4 dual inhibitor, YM-393059, on acute and chronic inflammation models.

Modulation of airway remodeling and airway inflammation by peroxisome proliferator-activated receptor gamma in a murine model of toluene diisocyanate-induced asthma.

Measurement of 2,4-toluene diisocyanate concentrations by different samplers.

Biophysical determinants of toluene diisocyanate antigenicity associated with exposure and asthma.